Annals of the Rheumatic Diseases

The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis.

Annals of the Rheumatic Diseases

Poddubnyy D, Navarro-Compán V, Torgutalp M, Arends S, Aydin SZ, Battista S, van den Bosch F, Bundy C, Cauli A, Davies J, Dougados M, Duruöz T, El-Zorkany B, Fong W, van Gaalen F, Garcia-Salinas R, Garrido Cumbrera M, Géher P, Gensler L, Grazio S, Huang F, Kishimoto M, Landewé R, Leung YY, Machado PM, Marzo-Ortega H, Meghnathi B, Molto A, Nikiphorou E, Ramiro S, Rudwaleit M, Saad CGS, Sepriano A, Wei J, Baraliakos X, van der Heijde D, ASAS

1995-2025: thirty years of ASAS and its contribution to the understanding of spondyloarthritis.

Annals of the Rheumatic Diseases

van der Heijde D, Navarro-Compán V, Landewé R, Sieper J, van Gaalen F, Gensler LS, Machado PM, Marzo-Ortega H, Poddubnyy D, Protopopov M, Ramiro S, Sepriano A, Baraliakos X

Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study.

Annals of the Rheumatic Diseases

Liew JW, Petrow E, Tilley S, LaValley MP, Roemer FW, Guermazi A, Lewis CE, Torner J, Nevitt MC, Lynch JA, Felson D

Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study.

Annals of the Rheumatic Diseases

Liew JW, Petrow E, Tilley S, LaValley MP, Roemer FW, Guermazi A, Lewis CE, Torner J, Nevitt MC, Lynch JA, Felson D

Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials.

Annals of the Rheumatic Diseases

Brown MA, Rudwaleit M, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, Deodhar A, van der Horst-Bruinsma I

POS0806 LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES.

Annals of the Rheumatic Diseases

X. Baraliakos, A. Deodhar, D. Van der Heijde, F. Van den Bosch, M. Magrey, W.P. Maksymowych, T. Tomita, H. Xu, U. Massow, C. Fleurinck, T. Vaux, C. Prajapati, J. Shepherd-Smith, A. Marten, L.S. Gensler

POS0194 FACTORS ASSOCIATED WITH RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING IL-17A INHIBITOR OR TNF INHIBITOR THERAPY: A POST-HOC ANALYSIS OF THE SURPASS STUDY.

Annals of the Rheumatic Diseases

D. Poddubnyy, J. Braun, P. Machado, V. Navarro-Compán, L.S. Gensler, K.G. Hermann, E. Quebe-Fehling, C.C. Pieterse, A. Readie, C. Gaillez, X. Baraliakos

AB0881 LONG-TERM SAFETY AND TOLERABILITY OF BIMEKIZUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM POOLED PHASE 2B/3 STUDIES.

Annals of the Rheumatic Diseases

P.J. Mease, D. Poddubnyy, A.M. Orbai, R.B. Warren, C. Fleurinck, R. Bajracharya, B. Ink, U. Massow, V. Shende, J. Shepherd-Smith, L. Peterson, K. White, R. Landewé, L.S. Gensler

POS0391 THE MSQUASH AS MEASUREMENT TOOL FOR DAILY PHYSICAL ACTIVITY: TRANSLATION AND CROSS-CULTURAL ADAPTATION INTO ENGLISH, FIELD-TESTING IN DIFFERENT RHEUMATIC DISEASES AND CLINICAL VALIDATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS.

Annals of the Rheumatic Diseases

Y.M. Van der Kraan, L.S. Gensler, D. Paap, E. Thovmasyan, N.S. Ausma, H. Kokol, M. Carbo, K. De Leeuw, K. Van der Geest, H. Bootsma, J.P.L. Spoorenberg, S. Arends

POS0215 LONG-TERM SAFETY AND EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 5-YEAR RESULTS FROM A PHASE 2B STUDY AND ITS OPEN-LABEL EXTENSION.

Annals of the Rheumatic Diseases

A. Deodhar, V. Navarro-Compán, D. Poddubnyy, L.S. Gensler, S. Ramiro, T. Tomita, H. Marzo-Ortega, C. Fleurinck, T. Vaux, U. Massow, D. Van der Heijde, X. Baraliakos

Pages